HIGH

Abbott i-STAT CG8+, EG7+, EG6+ Cartridges Recalled in 2025 Over Missing 510(k) Clearance

Abbott Point Of Care recalled 547,250 i-STAT CG8+, EG7+, and EG6+ cartridges distributed nationwide in the United States. The recall concerns lack of 510(k) premarket clearance for updated sample types and measurement ranges. Hospitals and clinicians should stop using these cartridges immediately and follow Abbott’s recall instructions.

Quick Facts at a Glance

Recall Date
August 21, 2025
Hazard Level
HIGH
Brand
Abbott Point Of Care
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Abbott Point Of Care Inc. or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

The i-STAT system uses disposable cartridges for point-of-care blood analysis in clinical settings. These cartridges are used with portable analyzers to rapidly measure various analytes and blood gas parameters.

Why This Is Dangerous

The hazard stems from the lack of regulatory clearance for updated cartridge types and measurement ranges. This could lead to regulatory noncompliance and potential uncertainty in diagnostic results.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Hospitals and clinics may need to halt use of these cartridges, potentially affecting testing workflows and requiring regulatory coordination.

Practical Guidance

How to identify if yours is affected

  1. Identify List Number 03P77-25 on cartridge packaging.
  2. Confirm the cartridge lot numbers in inventory match those included in the recall.
  3. Consult Abbott Point Of Care for clearance status before reuse.

Where to find product info

Refer to the recall notice and Abbott communications for identification codes beyond List Number 03P77-25.

What timeline to expect

Remediation timelines are set by Abbott and regulators; expect guidance to be issued by the manufacturer.

If the manufacturer is unresponsive

  • Escalate to hospital compliance or risk management offices.
  • File a formal inquiry with Abbott Point Of Care if responses are slow.

How to prevent similar issues

  • Verify regulatory clearance for new cartridge updates before stocking or using.
  • Implement supplier communications to capture regulatory status on new lots.
  • Document all recall communications and actions taken.

Documentation advice

Record lot numbers, List Number 03P77-25, dates of inventory, communications with Abbott, and internal decisions regarding use or disposal.

Product Details

Model numbers: List Number 03P77-25. All lot numbers. Distribution: US nationwide. Sold since: Unknown. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 547,250 units recalled
  • Lack of 510(k) clearance for updates to CG8+, EG7+, EG6+ cartridges
  • US nationwide distribution
  • Active recall as of 2025-08-21; FDA enforcement notice updated 2025-09-24

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
List Number 03P77-25
Affected States
ALL
Report Date
September 24, 2025
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more